Efficacy and safety of newly developed ganirelix acetate in infertile women for assisted reproductive technology: a prospective, randomised, controlled study-Reference-Cited by-同舟云学术

Efficacy and safety of newly developed ganirelix acetate in infertile women for assisted reproductive technology: a prospective, randomised, controlled study

Published:2022-03-07 Issue:6 Volume:42 Page:2197-2202
ISSN:0144-3615
Container-title:Journal of Obstetrics and Gynaecology
language:en
Short-container-title:Journal of Obstetrics and Gynaecology

Author:

Han E. Jung¹,Lyu Sang Woo¹,Kwak In Pyung¹,Kwon Hwang²,Choi Dong Hee²,Kim Jin Young¹,Park Han Moie¹,Kim Ji Won¹,Chang Eun Mi¹,Lee Hee Jun¹,Kim Min Kyung¹,Lee Hye Nam¹,Kim Jeong Yun³,Park So La³,Lee Woo Sik¹

Affiliation:

1. Department of Obstetrics and Gynecology, Fertility Center of CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, South Korea

2. Department of Obstetrics and Gynecology, Fertility Center of CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, South Korea

3. Clinical Development Department, LG Chem Ltd., Seoul, South Korea

Funder

LG Chem, Ltd., Seoul, South Korea

Publisher

Informa UK Limited

Subject

Obstetrics and Gynecology

Link

https://www.tandfonline.com/doi/pdf/10.1080/01443615.2022.2036955

Reference19 articles.

1. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

2. GnRH antagonists for treatment of polycystic ovarian syndrome

3. Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments

4. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Recombinant Human Follicle-Stimulating Hormone (Follitrope™) in Inducing Controlled Ovarian Stimulation in Infertile Women in Real-World Practice: a Prospective Cohort Study;Reproductive Sciences;2023-04-17